Aima

Overview

AIMA, a female-led team, is developing clinically tested CBD-derived products for personalized period pain management. Their first OTC product, OVY™, is a vaginal suppository directing targeted-CBD to reduce pain and inflammation safely and effectively.

Key Facts

Sector

Technology

Business model

SaaS

Stage

Growth

Team size

1-10

Focus Areas